Is alpha-lipoic acid (a natural antioxidant) better than no treatment or dummy treatment for nerve damage in people with diabetes?
Alpha-lipoic acid is sometimes used for the treatment of diabetic peripheral neuropathy. In this podcast, one of the authors, Caterina Delcea, talks with lead author Cristian Baicus, consultant in internal medicine from Colentina University Hospital Bucharest in Romania, about the January 2024 Cochrane review of this treatment. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - March 15, 2024 Category: General Medicine Authors: Cochrane Source Type: podcasts
Diabetes Core Update Diabetic Neuropathy Part 3 May 2022
In this special three-part series we will be doing a deep dive into diabetic peripheral neuropathy. In this third episode Drs. J. Robinson Singleton and Robin Marcus join our host, Dr. Neil Skolnik to discuss non-pharmacologic treatment of diabetic peripheral neuropathy. In part 1 we covered the epidemiology, pathophysiology, clinical manifestations, screening and diagnosis of diabetic peripheral neuropathy and in part 2 of the series we covered pharmacologic management. This series is supported by an unrestricted educational grant to the American Diabetes Association from Nevro, Inc. Presented by: Neil Skoln...
Source: Diabetes Core Update - May 16, 2022 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts
Special Edition: Diabetic Neuropathy, Part 2 – March 2022
In this special three-part series we will be doing a deep dive into diabetic peripheral neuropathy. In this second episode Dr. Rodica Pop-Busui joins our host, Dr. Neil Skolnik to discuss pharmacologic treatment of diabetic peripheral neuropathy. In part 1 we covered the epidemiology, pathophysiology, clinical manifestations, screening and diagnosis of diabetic peripheral neuropathy and in part 3 of the series we will cover non-pharmacologic management. This series is supported by an unrestricted educational grant to the American Diabetes Association from Nevro, Inc. Presented by: Neil Skolnik, M.D., Professo...
Source: Diabetes Core Update - March 22, 2022 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts
TWiV 872: COVID-19 clinical update #104 with Dr. Daniel Griffin
In COVID-19 clinical update #104, Daniel Griffin reviews effectiveness of mRNA vaccines among children, number of children affected by disease, accuracy of rapid antigen tests, CDC guidance for prevention strategies, monoclonal antibody effectiveness, predicting progression to severe respiratory failure from pneumonia, risk of long COVID after two vaccine doses, and peripheral neuropathy in long COVID. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Vaccine effectiveness 5-11 year olds (medRxiv) Vaccine effectiveness vs ED and UCE 5-12 year olds (medRxiv)...
Source: This Week in Virology - MP3 Edition - March 5, 2022 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
Diabetic Neuropathy Part I
In this special three-part series we will be doing a deep dive into diabetic peripheral neuropathy. In this first episode Dr. Rodica Pop-Busui joins our host, Dr. Neil Skolnik to discuss the epidemiology, pathophysiology, clinical manifestations, screening and diagnosis of diabetic peripheral neuropathy. In part 2 we will cover pharmacologic treatment and in part 3 of the series we will cover non-pharmacologic management. This series is supported by an unrestricted educational grant to the American Diabetes Association from Nevro, Inc. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medici...
Source: Diabetes Core Update - January 21, 2022 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts
A study of chemotherapy-induced peripheral neuropathy: the experiences and support needs of women following cancer treatment
When patients first receive a cancer diagnosis and go through treatment, they can be overwhelmed, and thus unprepared for the side effects that can occur during and even after treatment has ceased. In...
Author: VJOncology
Added: 12/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 11, 2017 Category: Cancer & Oncology Source Type: podcasts
How Do I Avoid Neuropathy As a Treatment Side Effect?
From our MPN Ask the Expert series, Patient Power viewer, Barb, asks a question about peripheral neuropathy as a side effect of treatment for essential thrombocythemia (ET). Dr. Prithviraj Bose from T...
Author: P2Professional
Added: 03/21/2017 (Source: Oncology Tube)
Source: Oncology Tube - March 22, 2017 Category: Cancer & Oncology Source Type: podcasts
How Do I Avoid Neuropathy As a Treatment Side Effect?
From our MPN Ask the Expert series, Patient Power viewer, Barb, asks a question about peripheral neuropathy as a side effect of treatment for essential thrombocythemia (ET). Dr. Prithviraj Bose from T...
Author: patientpower
Added: 03/21/2017 (Source: Oncology Tube)
Source: Oncology Tube - March 22, 2017 Category: Cancer & Oncology Source Type: podcasts
How to manage myelofibrosis patients on momelotinib who develop peripheral neuropathy
Haifa Kathrin Al-Ali, MD from the University of Leipzig, Leipzig, Germany discusses what can be done for myelofibrosis patients who develop peripheral neuropathy while treated with momelotinib. Dr Al-...
Author: VJHemOnc
Added: 07/25/2016 (Source: Oncology Tube)
Source: Oncology Tube - July 25, 2016 Category: Cancer & Oncology Source Type: podcasts
Peripheral Neuropathy
Peripheral neuropathy is a highly prevalent and morbid condition affecting 2% to 7% of the population. Patients frequently experience pain and are at risk of falls, ulcerations, and amputations. It is most commonly occurs in patients with diabetes. For most cases, the diagnosis and treatment of neuropathy can be made without complex testing or referral to specialists. Drs. Eva Feldman and Brian Callaghan from the University of Michigan Department of Neurology, authors of Distal Symmetric Polyneuropathy and Electrodiagnostic Tests in Polyneuropathy and Radiculopathy, explain how to manage neuropathy. (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - January 19, 2016 Category: Journals (General) Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts
What Can I Do to Ease the Effects of Chemotherapy-Induced Peripheral Neuropathy?
In this “Ask the Expert” segment featuring myeloma expert Dr. Robert Orlowski from MD Anderson Cancer Center, a community member wants to know how to ease the effects of chemotherapy-induced periphera...
Author: patientpower
Added: 10/18/2015 (Source: Oncology Tube)
Source: Oncology Tube - October 19, 2015 Category: Cancer & Oncology Source Type: podcasts
Scrambler therapy for the treatment of chemotherapy- induced peripheral neuropathy
Charles L. Loprinzi, MD, of the Mayo Clinic talks about scrambler therapy for the treatment of chemotherapy- induced peripheral neuropathy
Author: cancergiants
Added: 06/18/2015 (Source: Oncology Tube)
Source: Oncology Tube - June 18, 2015 Category: Cancer & Oncology Source Type: podcasts
Genetic Variant and Vincristine Peripheral Neuropathy in ALL
Interview with William E. Evans, PharmD, author of Association of an Inherited Genetic Variant With Vincristine-Related Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - February 24, 2015 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
Risks of combination NSAIDs-antithrombotics in patients with MI, vincristine-related peripheral neuropathy in children with ALL, management of patients with anticoagulation-induced intracerebral hemorrhage, kidney disease staging, and more.
Editor's Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the February 24, 2015 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - February 24, 2015 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy: A Randomized Clinical Trial
Interview with Ellen M. Lavoie Smith, PhD, author of Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy: A Randomized Clinical Trial (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - April 2, 2013 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
